{"id":"W4366754870","doi":"10.1016/j.conctc.2023.101143","title":"Anticoagulation in type 2 myocardial infarctions: Lessons learned from the rivaroxaban in type 2 myocardial infarctions feasibility trial","year":2023,"lang":"en","type":"article","venue":"Contemporary Clinical Trials Communications","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Canadian Cardiovascular Society","keywords":"Medicine; Myocardial infarction; Rivaroxaban; Clinical trial; Population; Placebo; Troponin; Internal medicine; Retrospective cohort study; Intensive care medicine; Physical therapy; Cardiology; Pathology; Alternative medicine; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01554879,0.0002888287,0.001524707,0.0004358332,0.0004027486,0.0001155522,0.0007139947,0.0004203694,0.0001315555],"category_scores_gemma":[0.04572567,0.000234973,0.0007880094,0.002895116,0.000450743,0.000362141,0.0006180452,0.001090958,0.0005561679],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001495613,"about_ca_system_score_gemma":0.0008226589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001098921,"about_ca_topic_score_gemma":0.0005496432,"domain_scores_codex":[0.9876819,0.007517896,0.003396502,0.0006058332,0.0004601264,0.0003377689],"domain_scores_gemma":[0.974392,0.02149162,0.0007400669,0.00291127,0.0002888986,0.0001761719],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02454386,0.0003699862,0.9401569,0.00001372795,0.0005816118,0.000007512318,0.0004968729,0.0002127514,0.0001219232,0.004023659,0.01153708,0.01793415],"study_design_scores_gemma":[0.03757448,0.0003521782,0.8297797,0.0001075168,0.0002509738,6.421629e-7,0.0005072921,0.001631195,0.000003588283,0.008033177,0.1215102,0.0002490189],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7346416,0.002000019,0.0001125282,0.2422004,0.005648843,0.008365205,0.0001615152,0.0005290587,0.006340877],"genre_scores_gemma":[0.9886261,0.005739152,0.000386456,0.0008816111,0.00214367,0.00007642584,0.001552387,0.00004145642,0.000552737],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2539846,"threshold_uncertainty_score":0.9623126,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.765640505794616,"score_gpt":0.5657367087481037,"score_spread":0.1999037970465123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}